La eritropoyetina (el factor Carnot), mucho más allá de los trastornos anémicos
PDF (Español (España))

How to Cite

García, G. A. (2021). La eritropoyetina (el factor Carnot), mucho más allá de los trastornos anémicos: actualidad y futuro. Revista Médica Sanitas, 14(1), 44-49. Retrieved from //revistas.unisanitas.edu.co/index.php/rms/article/view/305

Abstract

.

PDF (Español (España))

References

nelson J. Structure and function in cell Signaling. 1st edition. chichester, West Sussex (England): John Wiley & Sons Ltd; 2008.

Sitaramayya a (Editor). Signal transduction: pathways, Mechanisms and diseases. 1st edition. heidelberg (Germany): Springer-Verlag Berlin heidelberg; 2010. https://doi.org/10.1007/978-3-642-02112-1

Elliott SG, foote Ma, Molineux G (Editors). Erythropoietin, Erythropoietin factors, and Erythropoiesis -Molecular, cellular, preclinical, and clinical Biology. parnham MJ, Bruinvels J (Series Editors). Milestone in drug therapy. 2nd edition. Basel (Switzerland): Birkhäuser (part of Springer Science+Business Media); 2008.

foerster J, Rogers GM, paraskeva f et al (Editors). Wintrobe's clinical hematology. 12th ed. philadelphia, pa (uSa): Wolters Kluwer-Lippincott, and Williams & Wilkins; 2008.

Kaushansky K, Lichtman M, Beutler E et al. (Editors). Williams' hematology. 8th Ed. new york, ny (uSa): McGraw-hill professional; 2010.

provan d, Gribben JG (Editors). Molecular hematology. 3th ed. chichester, West Sussex (uK): WileyBlackwell (a John Wiley & Sons, Ltd., publication); 2010.

Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. ann hematol 2004; 83:673-686. https://doi.org/10.1007/s00277-004-0911-6

Brines M, cerami a. discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney int 2006; 70:246-50. https://doi.org/10.1038/sj.ki.5001546

Lundby c, olsen nV. Effects of recombinant human erythropoietin in normal humans. J physiol. 2010 aug 31. [Epub ahead of print]

clemmons d, Robinson icaf, christen y (Editors). iGfs: Local Repair and Survival factors throughout Life Span. Research and perspectives in Endocrine interactions Series. 1st edition. heidelberg (Germany): Springer-Verlag Berlin heidelberg; 2010. https://doi.org/10.1007/978-3-642-04302-4

fiordaliso f, chimenti S, Staszewsky L, et al. a nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. proc natl acad sci usa 2005; 102:2046-2051. https://doi.org/10.1073/pnas.0409329102

Berridge MV, et al. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 1988; 72: 970- 977. https://doi.org/10.1182/blood.V72.3.970.bloodjournal723970

Barletta Jf, cooper B, ohlinger MJ. adverse drug events associated with disorders of coagulation. crit care med 2010; 38(6 Suppl):S198-218. https://doi.org/10.1097/CCM.0b013e3181de11f9

Siren aL, fasshauer t, Bartels c et al. therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. neurotherapeutics 2009; 6:108-127. https://doi.org/10.1016/j.nurt.2008.10.041

chatagner a, hüppi pS, ha-Vinh Leuchter R et al. Erythropoietin and neuroprotection. arch pediatr 2010; 17 Suppl 3:S78-84. https://doi.org/10.1016/S0929-693X(10)70905-2

Schlüter Kd, Maxeiner h, Wenzel S. Mechanisms that regulate homing function of progenitor cells in myocardial infarction. minerva cardioangiol 2009; 57:203-17.

Mastromarino V, Volpe M, Musumeci MB et al. Erythropoietin and the heart: facts and perspectives. clin sci (Lond) 2011; 120:51-63. https://doi.org/10.1042/CS20100305

Krapf R, hulter hn. arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESa). clin J am soc nephrol 2009; 4:470- 80. https://doi.org/10.2215/CJN.05040908

Watanabe d, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. n Engl J med 2005; 353:782-792. https://doi.org/10.1056/NEJMoa041773

Szenajch J, Wcislo G, Jeong Jy et al. the role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells from clinic to bench - a critical review. Biochim Biophys acta 2010; 1806:82-95. https://doi.org/10.1016/j.bbcan.2010.04.002

Walker a. Breast milk as the gold standard for protective nutrients. J pediatr 2010; 156(2 Suppl): S3-7. https://doi.org/10.1016/j.jpeds.2009.11.021

Shiozawa y, Jung y, Ziegler aM et al. Erythropoietin couples hematopoiesis with bone formation. pLos one 2010; 5:e10853. https://doi.org/10.1371/journal.pone.0010853

Buemi M, Lacquaniti a, Maricchiolo G et al. Regenerative medicine: does Erythropoietin have a role? curr pharm des 2009; 15:2026-36. https://doi.org/10.2174/138161209788453194

Downloads

Download data is not yet available.